Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add filters








Language
Year range
1.
Chinese Journal of Experimental Traditional Medical Formulae ; (24): 121-130, 2022.
Article in Chinese | WPRIM | ID: wpr-940594

ABSTRACT

ObjectiveTo explore the molecular mechanism of Yishen Tongluo prescription in inhibiting the apoptosis of glomerular podocytes in rats with membranous nephropathy (MN) based on the miR-514a-5p/tumor necrosis factor superfamily member 15 (TNFSF15) signaling pathway. MethodEighty SD rats were pre-immunized and injected with cationized bovine serum albumin (C-BSA) into the tail vein for inducing MN, and the successfully modeled MN rats were randomly divided into the model group, high-, middle-, and low-dose (26.44, 13.22, 6.61 g·kg-1) Yishen Tongluo prescription groups, and benazepril (10 mg·kg-1) group, with 10 rats in each group, and another 20 healthy rats were classified into the normal group. Rats in each group were gavaged with the corresponding drugs, once a day, for four successive weeks. After the administration, the 24-hour urine total protein (UTP) level, serum total cholesterol (TC), triglyceride (TG), albumin (ALB), creatinine (SCr), and urea nitrogen (BUN) levels were measured. The miR-514a-5p and TNFSF15 mRNA expression levels in the rat kidney tissue were detected by real-time fluorescence quantitative polymerase chain reaction (Real-time PCR), and the expression levels of podocyte marker proteins Nephrin, Podocin, Podocalyxin, Synaptopodin, TNFSF15, and podocyte apoptosis-related proteins B lymphocytoma-2 (Bcl-2)-related X protein (Bax), Bcl-2-associated death promoter (BAD) protein, and B-cell lymphoma-extra large (Bcl-XL) by immunohistochemistry (IHC). Western blot was used to detect the expression levels of TNFSF15, Bax, BAD, Bcl-2, and BCL-XL in the rat kidney tissue. The apoptosis rate of rat kidney tissue was measured using the in situ end labeling method (Tunnel). ResultCompared with the normal group, the level of miR-514a-5p in the kidney tissue was significantly reduced (P<0.05), and the TNFSF15 mRNA expression was significantly increased (P<0.05). The expression levels of podocyte marker proteins Nephrin, Podocin, Podocalyxin, and Synaptopodin were down-regulated (P<0.05). The protein expression levels of TNFSF15, Bax, and BAD were increased (P<0.05), whereas the Bcl-2 and Bcl-XL protein expression levels were decreased (P<0.05). The number of apoptotic cells diminished significantly (P<0.05). Compared with the model group, the level of miR-514a-5p in the kidney tissue was significantly increased (P<0.05), while the level of TNFSF15 mRNA was significantly decreased (P<0.05). The expression levels of podocyte marker proteins Nephrin, Podocin, podocalyxin, and Synaptopodin were up-regulated (P<0.05), whereas the TNFSF15, Bax, and BAD protein expression levels were down-regulated (P<0.05). Bcl-2 and Bcl-XL protein expression levels rose (P<0.05). The number of apoptotic cells significantly decreased (P<0.05). ConclusionYishen Tongluo prescription reduces the apoptosis of rat kidney podocytes and alleviates the kidney injury of MN rats through the miR-514a-5p/TNFSF15 signaling pathway.

2.
Chinese Acupuncture & Moxibustion ; (12): 1216-1220, 2021.
Article in Chinese | WPRIM | ID: wpr-921035

ABSTRACT

OBJECTIVE@#To compare the effect of moxibustion combined with basic treatment and simple basic treatment on the clinical symptoms, renal function and hypercoagulable state in patients with idiopathic membranous nephropathy (IMN) of low to medium risk with spleen-kidney deficiency and blood stasis.@*METHODS@#A total of 60 patients with IMN of low to medium risk with spleen-kidney deficiency and blood stasis were randomized into an observation group (30 cases, 2 cases dropped off) and a control group (30 cases, 1 case dropped off). In the control group, the conventional basic treatment of anti-hypertension, regulating blood lipid and anti-coagulation was adopted. On the basis of the control group, moxibustion was applied at Shenshu (BL 23), Pishu (BL 20), Guanyuan (CV 4), Zusanli (ST 36) and Sanyinjiao (SP 6) in the observation group, once a day, 5 days a week continuously with 2 day interval. The treatment of 6 months was required in the both groups. Before treatment and 3 and 6 months into treatment, the total TCM syndrome score, the renal function indexes (24-hour urinary protein quantity [UTP], albumin [ALB], urea nitrogen [BUN] and creatinine [Scr]), the blood coagulation indexes (fibrinogen [FIB], D-Dimer [D-D], p-selection and von Willebrand factor [vWF]), total cholesterol (TC) and triacylglycerol (TG) levels were observed, and the therapeutic efficacy was evaluated on 3 and 6 months into treatment in the two groups.@*RESULTS@#The effective rates of 3 and 6 months into treatment were 78.6% (22/28) and 89.3% (25/28) in the observation group, which were higher than 62.1% (18/29) and 75.9% (22/29) in the control group respectively (@*CONCLUSION@#Moxibustion combined with basic treatment can effectively improve the clinical symptoms, renal function and renal microcirculation in patients with idiopathic membranous nephropathy of low to medium risk with spleen-kidney deficiency and blood stasis, the therapeutic effect is superior to the simple basic treatment.


Subject(s)
Humans , Acupuncture Points , Acupuncture Therapy , Glomerulonephritis, Membranous , Kidney/physiology , Moxibustion , Spleen
SELECTION OF CITATIONS
SEARCH DETAIL